Mankind Pharma, BDR Pharma partner for COVID drug Baricitinib in India
New Delhi: Mankind Pharma has recently announced that the company has partnered with BDR Pharmaceuticals International Pvt. Ltd for distributing the Anti-COVID19 drug Baricitinib under the trademark BARIKIND that received restricted emergency use approval, for use in combination with remdesivir.
According to the partnership, BDR Pharma will be manufacturing and marketing the product under a royalty free, limited and non-exclusive voluntary license from Eli Lilly and Company and Mankind Pharma will be distributing the same.
Mankind Pharma is the fourth largest pharmaceutical company in India headquartered in New Delhi, India.